source
- Biopharma capacity crunch shifts focus to ready-now manufacturing hubs like Middlesex County, NJDemand for biopharma manufacturing, especially cell and gene therapies, is growing faster than the ability to build new GMP-ready facilities, which can take years to complete. To keep pace, compan…
- Lilly adds $4.5 billion to Indiana manufacturing to boost weight-loss drug supplyEli Lilly & Co. announced an additional $4.5 billion investment in two of its three manufacturing sites in Lebanon, Indiana. The funding is aimed at expanding capacity for both its genetic therapie…